Business Context and Reporting Period
Prestige Consumer Healthcare Inc. (PBH) filed a Current Report on Form 8-K dated December 11, 2019. The filing reports the entry into a material definitive agreement regarding the company's credit facilities.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or total debt levels. It specifically details terms related to the Asset-Based Lending (ABL) Revolving Credit Facility:
- Applicable Margin: Initial margin set at 1.00% for LIBOR borrowings and 0.00% for base-rate borrowings.
- Margin Adjustments: Margins may increase to 1.25% or 1.50% (LIBOR) and 0.25% or 0.50% (base-rate) based on average excess availability.
- Commitment Fee: 0.25% per annum on unutilized commitments.
Material Changes
The company executed Amendment No. 7 to its ABL Credit Agreement, originally dated January 31, 2012. Key changes include:
- Maturity Extension: The maturity date of the ABL Revolving Credit Facility is extended to five years from the effective date of the amendment.
- Increased Flexibility: The amendment provides additional flexibility regarding investments, restricted payments, and debt incurrence.
Outlook, Risks, and Management Commentary
Management commentary is limited to the description of the amendment's terms. The filing notes that the amendment is intended to provide greater operational flexibility and extend the facility's term. No specific risks, contingencies, or forward-looking guidance regarding future financial performance are disclosed in this document.
Investor Verification Checklist
- Verify the full text of Amendment No. 7 (Exhibit 10.1) to understand specific covenants and conditions.
- Confirm the exact effective date of the amendment to calculate the new five-year maturity date.
- Review the company's most recent 10-K or 10-Q to determine current utilization of the ABL facility and total outstanding debt.
- Assess the impact of the new commitment fee (0.25%) on future interest expense relative to unutilized capacity.